Abbott sought compulsory license in 2007 US patent dispute

Sunday, 29 April 2007

(When the shoe was on the other foot, Abbott asked for a compulsory license, while criticizing Thailand for issuing compulsory licenses)
 

On the 12th of January 2007, Abbott Laboratories lost a bid in a U.S. District Court (the Western District of Wisconsin) for a compulsory license on a patent held by Innogenetics, Inc. that a judge and jury said Abbott infringed to manufacture and sell Hepatitis C virus (HCV) genotyping test kits.

 

Continue Reading

TACD issues resolution on IPR enforcement

On June 18, 2009, The Transatlantic Consumer Dialogue (TACD) issued a 2,000 word resolution on the enforcement of copyright, trademarks, patents and other intellectual property rights. The resolution is on the TACD web page here. A press release from the TACD IP-Working Group, with comments from several TACD members, is available on the web here.

Continue Reading

Uncategorized

KEI Statement at SCCR 18, May 27, 2009

Congratulations on your record setting re-election as chairman of the SCCR, and for your excellent guidance this week.

With regard to the draft questionnaire, KEI suggests it be expanded to address exceptions found in Article 44 of the TRIPS, regarding alternatives to injunctions.

KEI supports the proposal by Brazil, Ecuador and Paraguay for a treaty for reading disabled persons, which is correctly inclusive in terms of disabilities covered.

Continue Reading

Notes from Day one of WIPO SCP 13

WIPO’s five day 13th meeting of the Standing Committee on the Law of Patents (SCP) began on Monday, and will go through Friday. The agenda is quite full, as the SCP will consider four important reports written by the Secretariat.

SCP/13/2: Standards and Patents
SCP/13/3: Exclusions from Patentable Subject Matter and Exceptions and Limitations to the Rights
SCP/13/4: The Client-Attorney Privilege
SCP/13/5: Dissemination of Patent Information

Continue Reading

Uncategorized

PhRMA Special 301 submission on Thailand

The following discusses the 2009 PhRMA submission for the USTR Special 301 list on Thailand. Thailand is one of three Asian countries (China, Philippines and Thailand) that were singled out by PhRMA for the harshest treatment. The submission on Thailand covers several topics, including these:

Continue Reading